Cytogen, Inc. (KOSDAQ: A217330)
Health Care · Biotechnology · KR
₩2,695.00
-7.86% today · -9.6% 1Y
Cytogen, Inc. (KOSDAQ: A217330) operates in the Biotechnology industry within the Health Care sector. The company is valued at $46.75M.
Over the last twelve months the share price has lost 9.6%, trading between 2.59K and 11.20K.
Tweenvest scores Cytogen, Inc. across four factors: quality 54/100, value 50/100. Its strongest factor is quality.
A217330 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $46.75M
- Revenue (TTM)
- $17.68M
- P/E
- —
- EPS
- -456.81
- Dividend yield
- —
- Beta (5Y)
- 0.27
- 52-week high
- ₩11,200.00
- 52-week low
- ₩2,590.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.13M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kalaris Therapeutics, Inc.NasdaqGM: KLRS | $47.61M | $2.00 | -15.25% |
| 2invest AGDB: 2INV | $47.49M | €7.68 | -3.52% |
| Norda ASAOTCNO: NORD | $47.08M | Nkr86.00 | — |
| TaiRx, Inc.TPEX: 6580 | $46.82M | NT$13.55 | -6.87% |
| Solasia Pharma K.K.TSE: 4597 | $46.69M | ¥27.00 | -6.90% |
| OncoTherapy Science, Inc.TSE: 4564 | $46.54M | ¥18.00 | -5.26% |
| Apollomics, Inc.NasdaqCM: APLM | $46.34M | $21.10 | -1.86% |
| Prescient Therapeutics LimitedASX: PTX | $46.16M | AU$0.06 | -12.12% |
Figures last refreshed Oct 18, 2026.